Ma. Bayorh et al., EFFECTS OF MAXEPA ON SALT-INDUCED HYPERTENSION - RELATIONSHIP TO [H-3] NITROBENZYLTHIOINOSINE BINDING-SITES, Clinical and experimental hypertension, 18(1), 1996, pp. 37-49
Citations number
26
Categorie Soggetti
Pharmacology & Pharmacy","Cardiac & Cardiovascular System
We investigated the effects of dietary MaxEPA (a major source of eicos
apentaenoic acid in fish oil) supplementation on blood pressure (BP) r
esponses and heart rate (HII) of Dahl. salt-sensitive (SS) rats fed lo
w (0.4% NaCl) and high (8.0% NaCl) sodium diets. During a four week tr
eatment period, BP remained normotensive in rats on low salt diet but
was significantly elevated in those on high salt diet, causing 50% mor
tality. MaxEPA diminished the BP elevation and prevented the high salt
-induced mortality. HR was not affected by either salt diet alone but
was reduced in the presence of MaxEPA. At the end of the treatment per
iod, the distribution of [H-3]nitrobenzylthioinosine ([H-3]NBMPR) bind
ing, a putative marker of adenosine transport and metabolism, was esti
mated in selected rat tissues in order to evaluate the role of the pur
inergic system in the BP lowering effect of MaxEPA. Maximal [H-3]NBMPR
binding capacity (Bmax) in the kidney and platelets were 39% and 82%
lower, respectively, in rats on high salt diet than in those on low sa
lt diet. MaxEPA significantly blunted the decrease in Bmax in the kidn
ey but not in platelets and increased Bmax in heart (48%) of low salt
group. There were no changes in dissociation constants (Kd). The resul
ts suggest that MaxEPA can attenuate salt-induced hypertension, reduce
salt-induced mortality and protect the integrity of kidney NBMPR bind
ing sites in salt-induced hypertension.